Revenue
2022
2023
2024
2025
Propanc Biopharma, Inc. (PPCB)
Price$0.9980Cached quote
Net income
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Free cash flow
2011
2014
2015
2016
2019
Total cash / debt
CashTotal debt
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Research & development | $223,721 | $248,102 | $247,919 | $256,052 | $230,956 | $179,987 | $260,335 | $1.8M | $971,769 | $1.4M | $134,319 | $8,168 | $12,344 | $5,279 | $385,777 | — | — |
| Operating expenses | $57.3M | $1.5M | $1.8M | $2.0M | $1.8M | $3.5M | $2.6M | $4.0M | $5.7M | $6.9M | $1.7M | $761,221 | $1.4M | $11.6M | $2.2M | — | — |
| Operating income | −$57.3M | −$1.5M | −$1.8M | −$2.0M | −$1.8M | −$3.5M | −$2.6M | −$4.0M | −$5.7M | −$6.9M | −$1.7M | −$761,221 | −$1.4M | −$11.6M | −$2.2M | — | — |
| EBITDA | −$58.3M | −$1.5M | −$1.8M | −$2.0M | −$1.8M | −$3.5M | −$2.6M | −$4.0M | −$5.7M | −$6.9M | −$1.7M | −$760,683 | −$1.4M | −$11.6M | −$2.2M | — | — |
| Net income | −$58.9M | −$1.8M | −$2.7M | −$2.7M | −$2.0M | −$4.7M | −$5.8M | −$7.0M | −$7.9M | −$9.4M | −$3.4M | −$829,564 | −$1.4M | −$11.4M | −$2.2M | −$842,487 | −$443,849 |
| Basic EPSper basic share | -$371.25 | -$0.50 | -$45.00 | -$1.23 | -$20.00 | -$4.81 | -$274.25 | -$4,468.75 | -$56.00 | -$120.75 | -$0.50 | -$0.25 | -$0.50 | -$4.00 | -$0.75 | — | — |
| Diluted EPSper diluted share | -$371.25 | -$0.50 | -$45.00 | -$1.23 | -$20.00 | -$4.81 | -$274.25 | -$4,468.75 | -$56.00 | -$120.75 | -$0.50 | -$0.25 | -$0.50 | -$4.00 | -$0.75 | — | — |
Owners
Reported shareholders
Reported holdings Number of shares
View holders
| Holder | Shares held |
|---|---|
JANE STREET GROUP, LLC | 25.55K |
CITADEL ADVISORS LLC | 12.09K |
HRT FINANCIAL LP | 10.24K |
Caitong International Asset Management Co., Ltd | 2 |
Bars compare reported share counts. A matching total for this share class and reporting period is unavailable, so percentages are not shown.
Source: SEC Form 13F ↗Updated Sep 29, 2026 · Quarterly data